MLN is the official token of Enzyme. Founded in 2017, Enzyme is the global infrastructure for tokenized finance. Enzyme provides industry leaders with a comprehensive suites of Vault-As-A-Service and Financial Instruments products to manage on-chain assets efficiently, optimize operational processes, and develop innovative financial strategies tailored to their unique goals and challenges.
Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for MLN. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: MLN is a Strong Sell candidate.
MLN stock price ended at -- on 星期四, after dropping 0%
On Mar 26, 2026 00:00, the price of MLN fell by 0%, dropping from $3.34 to -- with 24h trading volume reaching -- MLN.